Clinical Trials Sponsored by Maruho Co., Ltd.

Total 10134 results

Maruho Co., Ltd.

Active, not recruiting

An Open-label, Phase 2 Study to Assess the Efficacy and Safety of Nemolizumab in Subjects With Systemic Sclerosis

Systemic Sclerosis

Japan
Maruho Co., Ltd.

Withdrawn

A Phase 2, Multicenter, Open-label Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pefcalcitol Ointment, 0.005%, Applied Topically Twice Daily (BID) for 8 Weeks in Adolescent Subjects 12 to < 17 Years of Age With Plaque Psoriasis

Psoriasis
Maruho Co., Ltd.

Completed

Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle

Rosacea

United States, France, United Kingdom, Germany, Australia, Canada, New Zealand, Netherlands, Sweden
Maruho Co., Ltd.

Completed

A Phase 2 Efficacy Study of CLS003 ICVT in Subjects With Cutaneous Warts.

Cutaneous Warts

Netherlands
Maruho Co., Ltd.

Completed

Phase III Study of ASP2151 in Herpes Simplex Patients

Herpes Simplex

Japan
Maruho Co., Ltd.

Completed

A 21 Day Pharmacokinetics Study in Papulopustular Rosacea

Papulopustular Rosacea

United States
Maruho Co., Ltd.

Completed

Dose-Finding Study of M516102 in the Treatment of Pruritus Associated With Atopic Dermatitis

Atopic Dermatitis

France, Germany, Poland, United Kingdom
Maruho Co., Ltd.

Completed

A Study to Evaluate the Safety and Efficacy of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts

Cutaneous Common Warts

United States
Maruho Co., Ltd.

Completed

A Phase 3 Study to Evaluate the Efficacy and Safety of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts

Cutaneous Common Warts

United States
Maruho Co., Ltd.

Completed

Study to Evaluate the Long-term Safety of a Once-Daily Omiganan Topical Gel

Rosacea

United States, United Kingdom, Canada, New Zealand, Australia, France, Sweden, Netherlands
Maruho Co., Ltd.

Unknown

Omiganan Twice a Day (BID) in Patients With Facial Seborrheic Dermatitis

Seborrheic Dermatitis

Netherlands
Maruho Co., Ltd.

Terminated

ICVT in HPV-induced Genital Lesions of Immunocompromised and Immunocompetent Patients

HPV-Induced Genital Lesions

Netherlands
Maruho Co., Ltd.

Completed

Phase III Study of ASP2151 in Herpes Zoster Patients

Herpes Zoster

Japan
Maruho Co., Ltd.

Completed

Topical Challenge With Omiganan and Imiquimod in Healthy Volunteers

Healthy

Netherlands
Maruho Co., Ltd.

Completed

Pharmacodynamics of Omiganan (CLS001) in Patients With Atopic Dermatitis

Atopic Dermatitis

Netherlands
Maruho Co., Ltd.

Completed

Open-label Study of ASP2151 in Herpes Simplex Patients

Herpes Simplex

Japan
Maruho Co., Ltd.

Completed

Study to Investigate the Efficacy and the Safety of M518101 in Plaque Psoriasis Patients

Plaque Psoriasis

United States
Maruho Co., Ltd.

Completed

A Twelve Week Safety and Efficacy Study in Rosacea

Papulopustular Rosacea

United States
Maruho Co., Ltd.

Completed

Study to Investigate the Efficacy and the Safety of M518101 in Psoriasis Patients

Plaque Psoriasis

United Kingdom
Maruho Co., Ltd.

Completed

Study to Evaluate the Safety and Efficacy of a Once-Daily CLS001 Topical Gel Versus Vehicle

Rosacea

United States, France, United Kingdom, Germany, Canada, Netherlands, New Zealand, Australia, Sweden
Maruho Co., Ltd.

Unknown

Topical Ionic Contra-Viral Therapy in Actinic Keratosis

Actinic Keratosis

Netherlands
Maruho Co., Ltd.

Completed

Pharmacodynamics of Omiganan BID in Patients With Atopic Dermatitis

Atopic Dermatitis

Netherlands
Maruho Co., Ltd.

Completed

Pharmacodynamics, Safety/Tolerability and Efficacy of Topical Omiganan in Patients With uVIN

Usual Type Vulval Intraepithelial Neoplasia (uVIN)

Netherlands
Maruho Co., Ltd.

Completed

A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris

Acne Vulgaris

United States
Maruho Co., Ltd.

Completed

Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris

Acne Vulgaris

United States
Maruho Co., Ltd.

Completed

First-in-Human Study of CLS003 ICVT in Subjects With Cutaneous Warts

Cutaneous Warts

Netherlands
Maruho Europe Limited
Maruho Co., Ltd.

Completed

Efficacy Study Comparing Topical M518101 and Vitamin D3 in Adult Psoriasis Patients

Plaque Psoriasis

Germany, Austria, Bulgaria, Hungary, Lithuania, Poland
BiomX, Inc.
Maruho Co., Ltd.

Not yet recruiting

A Study of Topical BX005-A in Subjects With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis
Maruho Co., Ltd.
Leiden University Medical Center

Completed

Pharmacodynamics, Safety and Efficacy of Topical Omiganan in Patients With External Genital Warts

Condylomata Acuminata (External)

Netherlands
Centre for Human Drug Research, Netherlands
Maruho Co., Ltd.

Completed

Intradermal LPS and Antibiotics

Inflammation; Skin

Netherlands
Centre for Human Drug Research, Netherlands
Maruho Co., Ltd.

Completed

Wound Healing in Healthy Volunteers

Wound Healing

Netherlands
Centre for Human Drug Research, Netherlands
Maruho Co., Ltd.

Recruiting

Anti-inflammatory Effects of Topical Erythromycin and Clindamycin in Acne Patients

Acne Vulgaris

Netherlands
Peking University
Marino Biotechnology Co., Ltd.

Unknown

Autologous CD19 CAR T Cells in Relapsed or Refractory B-cell Lymphoma

B-cell Lymphoma

China
Peking University
Marino Biotechnology Co., Ltd.

Unknown

Safety and Efficacy of iPD1 CD19 eCAR T Cells in Relapsed or Refractory B-cell Lymphoma

Relapsed or Refractory B-cell Lymphoma

China
Beijing Sanbo Brain Hospital
Marino Biotechnology Co., Ltd.

Unknown

Pilot Study of Autologous Chimeric Switch Receptor Modified T Cells in Recurrent Glioblastoma Multiforme

Glioblastoma Multiforme

China
China Meitan General Hospital
Marino Biotechnology Co., Ltd.

Unknown

Anti-mesothelin CAR T Cells for Patients With Recurrent or Metastatic Malignant Tumors

Mesothelin Positive Tumors

China
China Meitan General Hospital
Marino Biotechnology Co., Ltd.

Unknown

Chimeric Switch Receptor Modified T Cells for Patients With PD-L1+ Recurrent or Metastatic Malignant Tumors

Recurrent PD-L1+ Malignant Tumors | Metastatic PD-L1+ Malignant Tumors

China
Beijing Sanbo Brain Hospital
Marino Biotechnology Co., Ltd.

Unknown

Pilot Study of Autologous Anti-EGFRvIII CAR T Cells in Recurrent Glioblastoma Multiforme

Glioblastoma Multiforme

China
Huons Co., Ltd.
Humedix Co., Ltd.

Unknown

To Evaluate the Efficacy and Safety of Injection With HARA as Compared to Restylane® Lidocaine in Temporary Correction of Nasolabial Folds

Nasolabial FOLD

Korea, Republic of
InxMed (Shanghai) Co., Ltd.
InventisBio Co., Ltd

Recruiting

a Study to Evaluate the Safety and Efficacy of D-1553 Combined With IN10018 in KRAS G12C Mutant Solid Tumors

Solid Tumor

China
IlDong Pharmaceutical Co Ltd
YUNOVIA CO.,LTD.

Recruiting

Single Ascending Oral Dose Phase 1 Study of ID110521156 in Healthy Adult Subjects

Healthy Adult Subjects

Korea, Republic of
NanoCarrier Co., Ltd.
Orient Europharma Co., Ltd.

Recruiting

Combination Therapy With NC-6004 and Pembrolizumab in Head and Neck Cancer Subjects Who Have Failed Platinum Regimen

SCCHN

Croatia, Czechia, Hungary, Poland, Russian Federation, Serbia, Taiwan, Ukraine
CHABiotech CO., Ltd
Seoul CRO Co., Ltd.

Completed

Evaluation of Safety, Tolerability, and Efficacy of CordSTEM-DD in Patients With Chronic Low Back Pain

Chronic Low-back Pain | Disc Degeneration

Korea, Republic of
Hyundai Bioland Co., Ltd.
Medipost Co Ltd.

Completed

Efficacy and Safety of Allogenic Stem Cell Product(CARTISTEM®) for Osteochondral Lesion of Talus

Chondral or Osteochondral Lesion of Talus

Korea, Republic of
Yooyoung Pharmaceutical Co., Ltd.
CliPS Co., Ltd

Completed

Clinical Trial of YYC301 for Treatment of Osteoarthritis of the Knee

Osteoarthritis, Knee

Korea, Republic of
PegBio Co., Ltd.
Tigermed Consulting Co., Ltd

Completed

Dose-finding of PB-119 Administered Subcutaneously Once-weekly Versus Placebo in Drug-naïve T2DM Subjects

Type 2 Diabetes Mellitus

China
InventisBio Co., Ltd
InxMed (Shanghai) Co., Ltd.

Recruiting

Study to Evaluate D-1553 in Combination With IN10018 in Subjects With Solid Tumors

Solid Tumor

China
Orient Europharma Co., Ltd.
NanoCarrier Co., Ltd.

Terminated

Study of NC-6004 in Combination With 5-FU and Cetuximab in Patients With Head and Neck Cancer

Head and Neck Neoplasms

Taiwan
Orient Europharma Co., Ltd.
NanoCarrier Co., Ltd.

Completed

Combination Therapy With NC-6004 and Gemcitabine Versus Gemcitabine Alone in Pancreatic Cancer

Pancreatic Neoplasms

Taiwan, Japan, Hong Kong, Singapore, Philippines, Malaysia, Korea, Republic of
NanoCarrier Co., Ltd.
Orient Europharma Co., Ltd.

Completed

NC-6004(Nanoplatin) and Gemcitabine to Treat Pancreatic Cancer in Asia

Locally Advanced and Metastatic Pancreatic Cancer

Taiwan, Singapore

Clinical Trials Sponsored by Maruho Co., Ltd.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in France

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations